C22H28FNa2O8P
516.4 g/mol
Aktif Farmasötik İngredientTehlike
DEXAMETHASONE SODIUM PHOSPHATE
CAS2392-39-4EC219-243-0
Kategori
Aktif Farmasötik İngredient
Bileşik Sınıfı
Steroit
Birincil Kullanım
Farmasötik ham madde
Dexamethasone sodium phosphate is an organic sodium salt that serves as the disodium salt of dexamethasone phosphate. It functions as a glucocorticoid receptor agonist and is used as an active pharmaceutical ingredient in pharmaceutical manufacturing.
pharmaceutical raw materialglucocorticoid receptor agonist for research
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 2392-39-4
İlgili Bileşikler
GüçlüAynı ana yapı
DEXAMETHASONE SODIUM PHOSPHATE
CAS55203-24-2
glucocorticoid receptor agonist
BenzerBenzer yapıBenzerlik 0.76
Dexamethasone 21-mesylate
CAS2265-22-7
active pharmaceutical ingredient
ReferansAynı kategori
(2R,3R)-2,3-Dihydroxybutanedioic acid--3-(5-((2R)-2-aminopropyl)-7-cyano-2,3-dihydro-1H-indol-1-yl)propyl benzoate (1/1)
CAS239463-85-5
active pharmaceutical ingredient
ReferansAynı kategori
ARTICAINE HYDROCHLORIDE
CAS23964-57-0
dental amide-type local anesthetic
ReferansAynı kategori
Nicotinic acid N-oxide
CAS2398-81-4
pharmaceutical raw material
ReferansAynı kategori
Tolnaftate
CAS2398-96-1
active pharmaceutical ingredient
Referansstereoisomer of
Betamethasone sodium phosphate
CAS151-73-5
active pharmaceutical ingredient
Güvenlik Referansı
Tehlike
H302Harmful if swallowed
H351Suspected of causing cancer
H360May damage fertility or the unborn child
H361Suspected of damaging fertility or the unborn child
H373May cause damage to organs through prolonged or repeated exposure
Tanımlayıcılar
IUPAC Adı
disodium;[2-[(8S,9R,10S,11S,13S,14S,16R,17R)-9-fluoro-11,17-dihydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl]-2-oxoethyl] phosphate
InChIKey
PLCQGRYPOISRTQ-FCJDYXGNSA-L
SMILES
C[C@@H]1C[C@H]2[C@@H]3CCC4=CC(=O)C=C[C@@]4([C@]3([C@H](C[C@@]2([C@]1(C(=O)COP(=O)([O-])[O-])O)C)O)F)C.[Na+].[Na+]
Eş Anlamlılar (74)
- Dexamethasone sodium phosphate (JAN/USP)
- Dexamethasone sodium phosphate for peak identification, European Pharmacopoeia (EP)
- Dexamethasone sodium phosphate, British Pharmacopoeia (BP)
- Dexamethasone sodium phosphate, European Pharmacopoeia (EP)
- Dexamethasone sodium phosphate, United States Pharmacopeia (USP)
- 2392-39-4 (disodium)
- Ak-Dex
- Baldex
- Cebedex
- Colvasone
- DMT SUIK
- Dalalone
- Dalalone (TN)
- Decadron phosphate
- Decaject
- Decdan
- Dekasol LA
- Dex-A-Vet Injection
- Dexabene
- Dexacen
- Dexadreson
- Dexagel
- Dexagro
- Dexair
- Dexaject SP
- Dexamethasone SP
- Dexium-SP
- Hexadrol Injectable
- Ludaxine
- Maxidex Ointment
- Megacort
- Onadron
- Orgadrone
- Prodex
- ReadySharp Dexamethasone
- Ropidex
- SOLUPEN N
- Soldesam
- Solu-Decadron
- Solurex
- Spersadox
- Topidex
- Viadox
- dexamethasoni natrii phosphas